Complications of intravenous immune globulin treatment in neurologic disease
暂无分享,去创建一个
[1] Bethany J Figg,et al. National Institute of Child Health and Human Development , 2013 .
[2] W. Pettinger,et al. Autonomic ganglionitis with severe hypertension, migraine, and episodic but fatal hypotension , 1996, Neurology.
[3] Adams Ew. A brief history of the School of Veterinary Medicine at Tuskegee University. , 1996 .
[4] T. Bertorini,et al. Complications of intravenous gammaglobulin in neuromuscular and other diseases , 1996, Muscle & nerve.
[5] R. Lisak. Arthritis associated with circulating immune complexes following administration of intravenous immunoglobulin therapy in a patient with chronic inflammatory demyelinating polyneuropathy , 1996, Journal of the Neurological Sciences.
[6] M. Levitt,et al. A Comparison of Symptoms after the Consumption of Milk or Lactose-Hydrolyzed Milk by People with Self-Reported Severe Lactose Intolerance , 1995 .
[7] J. Pérez-Oteyza,et al. Hepatitis C and immune globulin. , 1995, New England Journal of Medicine.
[8] S. Frøland,et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. , 1994, The New England journal of medicine.
[9] W. Litchy,et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy , 1994, Annals of neurology.
[10] J. Kissel,et al. Treatment of stiff‐man syndrome with intravenous immunoglobulin , 1994, Neurology.
[11] M. Dalakas,et al. Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk Factors , 1994, Annals of Internal Medicine.
[12] R. T. Lie,et al. A Population-Based Study of the Risk of Recurrence of Birth Defects , 1994 .
[13] D. Fish,et al. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy) , 1994, Neurology.
[14] R. Griggs,et al. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease , 1994, Annals of neurology.
[15] M. Gheorghiade,et al. WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS , 2010 .
[16] S. Misbah,et al. Adverse Effects of Intravenous Immunoglobulin , 1993, Drug safety.
[17] M. Dalakas,et al. Treatment of inclusion‐body myositis with high‐dose intravenous immunoglobulin , 1993, Neurology.
[18] Robert G. Miller,et al. Multifocal motor neuropathy: Response to human immune globulin , 1993 .
[19] J. Mendell,et al. Acute renal failure resulting from intravenous immunoglobulin therapy. , 1993, Archives of neurology.
[20] M. Ballow,et al. Safety of intravenous immunoglobulin. , 1993, Archives of neurology.
[21] P. Brock,et al. Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[22] F. Van de Werf,et al. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group. , 1992, The New England journal of medicine.
[23] S. Linder. Nobel seminar: Molecular medicine — cell biology in disease Cancer and HIV: from viral genes to therapy? , 1992, Journal of internal medicine.
[24] D. Fulton,et al. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. , 1992, The Journal of pediatrics.
[25] C. Putterman,et al. Transient neutropenia induced by intravenous immune globulin. , 1992, The New England journal of medicine.
[26] K. Anand,et al. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. , 1992, The New England journal of medicine.
[27] Lippincott Williams Wilkins,et al. Assessment: Magnetoencephalography (MEG) , 1992 .
[28] D. Bridge,et al. Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis , 1992, Neurology.
[29] J. Piette,et al. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. , 1991, The American journal of medicine.
[30] D. Ross. Monitoring L-thyroxine therapy: lessons from the effects of L-thyroxine on bone density. , 1991, The American journal of medicine.
[31] M. Nicholls,et al. Haemolysis induced by intravenously‐administered immunoglobulin , 1989, The Medical journal of Australia.
[32] R. Gale,et al. Clinical uses of intravenous immunoglobulins. , 1988, Seminars in hematology.
[33] T Smith,et al. New Year Message , 1988, British medical journal.
[34] J. Mcmillan,et al. Eczema after intravenous infusion of immunoglobulin. , 1987, British medical journal.
[35] T. Delamothe. The OPCS: many (more) happy returns? , 1987, British medical journal.
[36] E. Fitzsimons,et al. ALOPECIA AFTER IMMUNOGLOBULIN INFUSION , 1987, The Lancet.
[37] G. Herrera,et al. Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. , 1987, The American journal of medicine.
[38] D. Cournoyer,et al. Hemolytic anemia following intravenous gamma globulin administration. , 1987, The American journal of medicine.
[39] H. Scher,et al. Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors. , 1987, The American journal of medicine.
[40] E. Gelfand,et al. Corticosteroids for prevention of adverse reactions to intravenous immune serum globulin infusions in hypogammaglobulinemic patients. , 1986, The American journal of medicine.
[41] López Piñero Jm,et al. New material and information about the History of the plants of New Spain by Francisco Hernandez , 1994 .
[42] T. Scott. Neurosarcoidosis , 1993, Neurology.
[43] C. Diskin,et al. Pharmacologic intervention to prevent hemodialysis vascular access thrombosis. , 1993, Nephron.
[44] R. Brunkhorst,et al. Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: a case report and review of the literature. , 1993, Nephron.
[45] A. Prince,et al. Viral safety of solvent-detergent treated blood products. , 1993, Developments in biological standardization.
[46] H. Suomalainen,et al. Local immune response in patients with cow milk allergy: follow-up of patients retaining allergy or becoming tolerant. , 1992, The Journal of pediatrics.
[47] B. Donatini. Transient renal dysfunction in diabetic patients after IVIg therapy. , 1992, Journal of internal medicine.
[48] J. Kobosko,et al. Renal toxicity of intravenous immunoglobulin. , 1992, Clinical nephrology.
[49] M. Dalakas,et al. High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. , 1990, Neurology.
[50] J. Goodgold. Ethics, education and empire. , 1979, Archives of Physical Medicine and Rehabilitation.